Clinical Trials List
2025-02-20 - 2027-10-29
Phase II
Recruiting4
ICD-10C18.9
Malignant neoplasm of colon, unspecified
ICD-10C7A.029
Malignant carcinoid tumor of the large intestine, unspecified portion
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.9
Malignant neoplasm of colon, unspecified
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂嘉偉 無
- 張境夫 無
- 黃文冠 無
- 余紹銘 無
- Mengting Peng 無
- Chia-Hsun Hsieh 無
- Ming-Mo Hou 無
- Jen-Shi Chen 無
- 賴盈傑 無
- Wen-Chi Chou 無
- Yung-Chia Kao 無
- 黃振洋 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 呂理駿 無
- Chih-Hung Hsu 無
- Chiun Hsu 無
- TA-CHEN HUANG 無
- YU-YUN SHAO 無
- 莊建淮 無
- 陳國興 無
- Ann-Lii Cheng 無
- 林宗哲 無
- 梁逸歆 無
- 陳柏邑 無
- TSUNG-HAO LIU 無
- Ying-Chun Shen 無
- 張端瑩 無
- 郭弘揚 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
120 participants
